EUVIMEDEUVIMED entdecken
Crossref

Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy

Wenjie Duan, Qian Shen, Linjie Ju, Zhongxi Huang, Jiaying Geng, Qiong Wu, Changmin Yu iD, Jifu Wei iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c08842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Wenjie Duan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jiangsu Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Doxorubicin, Nanoparticles, MicroRNAs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Excellent Postdoctoral Program of Jiangsu Province, National Health Council Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDoxorubicinNanoparticlesMicroRNAsBiomimetic MaterialsHumansFemaleAnimalsMiceGenetic TherapyCell Line, TumorSilicon DioxideCell ProliferationDrug Carriers

Stichwörter der Autor:innen

MONSeTNBChomologous targetingresponsive biodegradationsynergistic chemo-gene therapy

Substanzen

DoxorubicinMicroRNAsMIRN34 microRNA, humanSilicon DioxideDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmacy, Jiangsu Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, 42 Baiziting Road, Nanjing 210009, China.
  • Key Laboratory of Flexible Electronics (KLOFE), School of Flexible Electronics (Future Technologies) & Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), 30 South Puzhu Road, Nanjing 211816, C…

ORCID-Profile: Changmin Yu, Jifu Wei

Förderung

  • National Key Research and Development Program of China
  • Excellent Postdoctoral Program of Jiangsu Province
  • National Health Council Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine

Zitieren

APA

Duan, W., Shen, Q., Ju, L., Huang, Z., Geng, J., Wu, Q., Yu, C., & Wei, J. (2024). Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c08842

Vancouver

Duan W, Shen Q, Ju L, Huang Z, Geng J, Wu Q, et al. Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c08842

BibTeX
@article{Duan2024,
  author = {Duan, Wenjie and Shen, Qian and Ju, Linjie and Huang, Zhongxi and Geng, Jiaying and Wu, Qiong and Yu, Changmin and Wei, Jifu},
  title = {Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c08842}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche